If the company believes that they will only generate $20M (CDN$) revenues in 2022, management better sit in a crisis management session to figure out what's wrong in their approach to 'sales'.
Generating $ 25,000,000 in 2 full years with that extraordinary a product line, addressing a fast growing plant based food market (in general) would be percieved as a failure to the market.
Let's first see what Q4 will show and how Cannaccord will react.
The other development we shall follow closely in Q1 will be the uplisting situation.